Skip to content
The Nexus
DossierENTITY

Replimune Group

Coverage of Replimune Group in the Nexus archive.

Earliest in view: May 29 · 13:14 UTCMost recent: May 29 · 13:14 UTC
Co-mentioned in this coverage
Allogeneorganization1David Changperson1WHOorganization1Bundibugyo Ebola outbreaktopic1FDAorganization1
Recent coverage
  • BUSINESSMay 29 · 13:14 UTCSTAT NEWS
    STAT+: Allogene CEO David Chang stepping down

    Allogene CEO David Chang is stepping down. WHO experts recommend an antiviral and monoclonal antibodies for the Bundibugyo Ebola outbreak. Replimune Group agreed to resubmit its melanoma drug to the FDA after prior rejections.